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                                                                           fatti non foste a viver come bruti, 
                                                                           ma per seguir virtute e canoscenza 
“you were not made to live like brutes or beasts,  
but to pursue virtue and knowledge”                                                                          
                Dante Alighieri (1265-1321) 
                                                                        La Divina Commedia, Inferno XXVI; 119-120 
 
 
 
  
ABSTRACT 
This thesis was designed to study causes and effects of changes in plasma sodium and 
osmolality during pregnancy and labour. 
The physiological changes of early pregnancy include reduction in plasma sodium and 
osmolality, as well as increased ventilation with reduced arterial pCO2. These changes are 
usually considered due to progesterone. Some studies have however correlated these two events 
and found that reduction in osmolality and strong ion difference (SID, the difference between 
strong cations and anions) may predict respiratory changes in pregnant women. We 
hypothesised that changes in osmolality should influence ventilation also in non-pregnant 
women and men, and we therefore studied the ventilatory response to lowered and increased 
osmolality in healthy volunteers, ten men and nine women. Ingestion of water and intravenous 
infusion of hypertonic saline 3% caused osmolality to decrease and increase, respectively. SID 
and base excess decreased in both conditions, and a respiratory compensation was observed 
during water loading, but although the metabolic acidosis was more pronounced during salt 
loading, no respiratory compensation was observed. The principal influence of osmolality on 
ventilation could be inhibitory when osmolality is increased, but this inhibitory effect could 
cease at decreased osmolality.  
The hyperventilation observed during pregnancy often exceeds the respiratory compensation 
observed in our study participants, but this remains to be explained.  
We also studied the feto-maternal osmotic and electrolyte relationship, and contrary to the 
literature, we found that fetal plasma sodium and osmolality were higher than maternal levels. 
Our results indicated that the physiologic hyponatraemia of pregnancy caused both a 
compensatory respiratory alkalosis that favours removal of fetal CO2, as well as an osmotic 
gradient that favours water transport to the fetus. This unifying explanation of maternal 
physiologic adaptation and feto-maternal relationship differs from the conventional 
explanatory model that considers the respiratory alkalosis primary, and the metabolic acidosis 
compensatory. 
In addition to the physiological lowering of plasma sodium in the pregnant woman, 
hyponatraemia may develop during labour. We included 287 women during labour in a 
prospective observational study, and found that hyponatraemia was common following long 
lasting labour.  Sixteen women (26 %) of those who received more than 2.5 liters of fluid during 
labour developed hyponatraemia ≤130mmol/L. Multivariate analysis revealed that 
hyponatraemia was significantly correlated to total fluid volume, but not to oxytocin or epidural 
 analgesia. All women consumed a similar hourly fluid volume of approximately 300 milliliter, 
but during long lasting labour, probably with an increased secretion of vasopressin, free water 
clearance was reduced, and hyponatraemia could develop.  
Reduction in plasma sodium during labour also significantly correlated to instrumental 
delivery. We therefore studied the effect of hyponatraemia on human myometrium in an in 
vitro study. Hyponatraemia induced reversible changes with increased frequency of 
contractions and also of multiphasic contractions. These changes could indicate decreased 
myometrial contractility. In the second part of the study we found that initial multiphasic 
response to increasing doses of oxytocin was significantly more frequent in the hyponatraemic 
solution. These results indicate that hyponatraemia could be one of several factors leading to 
dystocia. Electrolyte free solutions should not be administered during labour, and a bedside 
registration of fluid consumption would be a simple preventive measure against 
hyponatraemia.  
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LIST OF ABBREVIATIONS 
ABL Acid base laboratories 
ADH Antidiuretic hormone 
ANCOVA Analysis of covariance 
ANG II Angiotensin II 
ANOVA Analysis of variance 
AP Action potential 
A-tot Total weak non-volatile acids (mostly albumin) 
AUC Area under the curve 
AVP Arginine vasopressin 
AVPase Enzyme that degrades AVP 
BE Base excess 
BMI Body Mass Index (kg/m2) 
C-terminal End with the atom C, as opposed to end with the atom N 
DI Diabetes Insipidus 
ET End tidal 
G Gauge, measure of needle size ( higher G, smaller size) 
HELLP Syndrome of haemolysis, elevated liver enzymes, low 
platelets 
ISE Ion specific electrode 
IU International unit 
mEq/L Milliequivalent per liter 
Mg Milligram, 10-3 gram 
Ml Milliliter, 10-3 liter 
µl Microliter, 10-6 liter 
Mmol Millimol, 10-3  mole 
mOsm Milliosmole, 10-3 osmole 
mU Milliunit, 10-3 Unit 
OT Oxytocin 
PaCO2 Arterial partial pressure of CO2 
 Pmol Picomole, 10-12 mole 
SD Standard deviation 
SIAD Syndrome of inappropriate ADH secretion 
SID Strong ion difference 
UA Unmeasured anions 
V1,V2,V3 Vasopressin receptors V1,V2,V3 
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INTRODUCTION  
The physiological adaptation to pregnancy is often evident long before the growing womb 
reveals fetal presence. The florid appearance of the pregnant woman with glowing skin and 
rosy lips are caused by vasodilation and increased cardiac output (1). Other well known 
characteristics are morning sickness, and increased ventilation with lowered arterial pCO2 
(PaCO2). All changes are often referred to as “progesterone induced” (1), however, recent 
studies indicate more complex explanations to these profound and reversible physiological 
adaptations to pregnancy.  
The significant decrease in systemic vascular resistance and increased cardiac output are now 
believed to be induced by relaxin, a hormone produced by the corpus luteum (2). Relaxin is 
also believed to be responsible for the lowering of plasma osmolality (3), another characteristic 
of early pregnancy. Moreover, studies have found a correlation between reduced osmolality 
and increased ventilation (4,5). 
In addition to the physiological hyponatraemia of pregnancy, a further lowering of plasma 
sodium may develop during labour (6,7). Observational studies and case reports have not 
infrequently described maternal and fetal hyponatraemia following labour (8-10). In more 
recent years voluntary overdrinking has replaced iatrogenic causes of hyponatraemia (7). Feto-
maternal osmotic relationship is an important factor for water transport, however data reported 
in literature are scarce, and most often dated. One of our studies showed that plasma sodium 
reduction during labour correlated with instrumental delivery. Myometrial contractility 
involves complex interaction of ions but, to the best of my knowledge, no human study has 
addressed the possible impact of hyponatraemia.  
 BACKGROUND 
The physiological adaptation to pregnancy involves literally every organ and system in the 
pregnant woman. This thesis was designed to study causes and effects of changes in plasma 
sodium and osmolality during pregnancy and labour. Below follows a description of the 
physiological changes that are of main interest for the topic of this thesis 
  Physiological changes of pregnancy. The role of relaxin   
Significant physiological changes are evident in early stages of pregnancy, indeed, these 
changes are detectable already in the luteal phase of the menstrual cycle (4,5). Lowering of 
plasma osmolality and sodium, and also the osmotic threshold for thirst are detectable after 
ovulation. Water and sodium retention continues following conception causing mild 
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hyponatraemic hypervolaemia. Reduction in plasma osmolality reaches approximately 10 
mOsm/kg mainly as a result of a decrease in plasma sodium by 3-5 mmol/L. By 12 weeks of 
gestation this adaptation has stabilised, and plasma osmolality remains low until after 
delivery (4,11). 
Decrease in PaCO2 is observed simultaneously with these early changes and progesterone is 
commonly considered responsible (1). However, some studies indicate that reduction of 
osmolality and strong ion difference (SID) may be the cause of increased ventilation (4,12). 
Vasodilation, increased blood volume and cardiac output are other more well known changes 
that occur in early pregnancy (1). The increase in cardiac output together with renal 
vasodilation increases glomerular filtration rate with approximately 50 %. Blood pressure, 
particularly diastolic blood pressure, is reduced during pregnancy, and the response to 
vasopressors is attenuated (1).  
The hormone relaxin, secreted from the corpus luteum, is now believed to initiate the process 
of metabolic and haemodynamic adjustments to pregnancy previously attributed to 
progesterone (2,13). Relaxin is a 53 amino acid peptide hormone characterised by a structure 
similar to insulin. Discovered in 1926 (14), relaxin was found to relax the symphysis in 
pregnant mares, hence the name.  
The important role of relaxin for adaptation to pregnancy was later recognised (2). Relaxin 
plasma levels increase when pregnancy is established, reaching maximum levels at the end 
of the first trimester. Thereafter relaxin is present throughout the remaining gestation, but at 
lower levels. 
Some researchers have considered that the systemic vasodilation leading to “underfilling” 
initiates water and sodium retention (12). However, studies in rodents showed comparable 
time-course of renal vasodilation and reduction in plasma osmolality (15). Recent studies 
also indicate a more complex mechanism, as relaxin affects the release of oxytocin and 
vasopressin by central stimulation (3,16,17). Animal studies show that osmosensors respond 
to circulating hypertonicity, angiotensin II (ANG II) and relaxin, and that relaxin has an effect 
similar to hypertonicity on the osmosensitive neurons in the hypothalamus (18).  
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 OSMOLALITY, VASOPRESSIN, AND OXYTOCIN 
Sodium and the corresponding anions are the main osmoles in extracellular fluid, and sodium 
concentration mainly reflects body water content. Extracellular osmolality can be determined 
by cryoscopy and may also be calculated by the formula   
Osmolality (mOsm/kg)  =  (2[Na]mmol/L +  [urea] mmol/L + [ glucose ]mmol/L) (19) 
Reabsorption of water in the collecting ducts of the kidney is controlled by vasopressin, also 
known as the antidiuretic hormone (ADH), in turn regulated by plasma osmolality. 
Extracellular fluid volume is governed by the sodium homeostasis, and renal sodium excretion 
is regulated by the renin-angiotensin-aldosterone-axis.  
Vasopressin and oxytocin (OT) are small neuropetides present in all mammals. Probable 
precursors, similar in structure and analogue in function, are present also in invertebrates and 
the origin of this signalling system dates back 600 million years (20). Vasopressin and OT 
probably originated by duplication of the ancestral vasotocin gene (21). The human vasopressin 
contains arginine, and is therefore often denominated arginine-vasopressin (AVP). 
 OT and AVP differ only in two of nine amino acids, and both hormones are involved in a wide 
range of physiological processes including reproduction, renal water reabsorption, blood 
pressure control, modification of social behaviour, and neonatal adaptation. Half-time life of 
AVP and OT in plasma is short, around 4-20 minutes (22). Release of AVP is controlled by 
central osmoreceptors situated in areas in the hypothalamic region that are at least partly located 
outside the blood-brain barrier (23). Pain, stress, and fear are non-osmotic stimuli for AVP 
secretion. Hypovolaemia and hypotension are however the most potent stimuli for secretion, 
and may cause water retention even in the presence of hypoosmolality, whereas hypervolaemia 
blunts the release of AVP in response to increase in osmolality (24). 
OT is synthetised in the hypothalamus, in nerve cells close to those who synthetise AVP, and 
also transported to the posterior hypophysis where it is released. Lactation appears to be the 
only function depending exclusively on OT (25). OT stimulates myometrial contraction and is 
commonly administered for induction and augmentation of labour, but is not essential for 
labour and delivery (26). OT may also cause water retention by stimulation of the V2 
vasopressin receptors in the kidney. The infusion rate of OT must exceed 20 mU/min to cause 
antidiuresis in humans (27) which will be reached at the infusion rate of 20 milliliter per hour 
of OT 5 IU in 500 milliliter. However, the antidiuretic effect will cease when infusion is 
stopped. 
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The AVP receptors, V1, V2, V3, and the OT-receptor belong to the G protein-coupled receptors 
and are structurally very similar explaining the pronounced cross reactivity of the two 
hormones (20). Noteworthy, whereas AVP and OT have similar affinity for the OT receptor, 
the affinity for V2 receptor by OT is 30-fold lower compared to AVP (28). The AVP receptors 
are not down regulated during prolonged stimulation, whereas the OT receptor effectively is 
down regulated during prolonged stimulation during labour (26). Studies have also shown that 
the myometrium is more sensitive to AVP than to OT (26). 
V1 receptors (formerly V1a) are found in the central nervous system, vascular smooth muscle 
cells, liver, and platelets. The foremost effect is vasoconstriction, and 90 % of circulating AVP 
is bound to platelets. V2 receptors are found in the collecting ducts of the kidney, and 
stimulation leads to increased water reabsorption through incorporation of aquaporine 2 (22). 
V3 receptors (formerly V1b) are found in the adenohypophysis, and corticotropin is released 
following stimulation. 
 Copeptin 
AVP is produced as a larger precursor called preprovasopressin in the paraventricular and in 
the supraoptic nucleus of the hypothalamus (29). During axonal transportation to the 
neurohypophysis the provasopressin is separated from the signal peptide, thereafter AVP is 
separated from neurophysin and the C-terminal peptide, also called copeptin. OT lacks the C-
terminal peptide, all copeptin therefore originates from the provasopressin. 
The study of AVP is difficult as half life is short, and the analysis is hampered with 
methodological difficulties and high costs. Copeptin was first described in 1972 (30), but a 
reliable immunoluminometric assay for analysis of copeptin was developed first by 
Morgenthaler in 2006 (31). The identification of copeptin, its release in a 1:1 manner with 
AVP, together with commercially available methods for analysis have therefore brought new 
insight into the physiological properties and importance of AVP. The analysis requires only 50 
µl of blood, and the cost although still high, is currently decreasing. Analysis of copeptin may 
therefore become important also in everyday clinical practice (32). 
Copeptin levels in physiological and pathological conditions were first described in adults (33). 
From 5 pmol/L at rest, copeptin levels increased with dehydration and moderate stress, 
reaching the highest level during septic shock when a 20-fold increase in copeptin was 
described (30,33). Birth has been recognised as an extremely stressful experience for the fetus 
with a surge in stress hormones (34). Wellman found that copeptin in newborn immediately 
after vaginal delivery exceeded by 5-10 times the highest levels previously described in adults 
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(35). The highest levels in newborn were found following prolonged labour and instrumental 
vaginal delivery, and copeptin levels were inversely correlated to umbilical arterial pH at birth. 
In contrast, values close to resting levels were found in infants delivered by planned caesarean 
section. Copeptin was also higher in arterial compared to venous umbilical blood, indicating 
fetal origin of copeptin, confirming previous research that indicated independent fetal 
osmoregulation (36). 
 Respiratory effects of osmolality 
Osmolality and strong ions have been proposed as important contributors to chemical 
respiratory control (37,38). Several studies show that changes in osmolality may influence 
ventilation. Increased osmolality inhibited panting in dogs (39) and opposed sweating and 
ventilatory response to hyperthermia in humans (40,41). This is interpreted as suppression of 
water dependent thermoregulation in dehydrated mammals, as the preservation of body fluid 
is preferred even at the cost of increased core temperature (42). On the other hand, animal 
studies also indicated that decreased osmolality stimulates ventilation (5). Most human studies 
in this field have employed a spontaneously occurring human model, as decrease in osmolality 
and SID are observed in pregnancy and these changes are present to a lesser degree also in the 
luteal phase of menstruation (43). These studies showed that PaCO2 was predicted by changes 
in osmolality and SID (4,38) and also correlated progesterone to PaCO2. However, relaxin, 
secreted by the corpus luteum already during the luteal phase of the menstrual cycle, has 
replaced progesterone as the hormone considered responsible for lowering of plasma sodium 
in early pregnancy (44). 
Release of AVP is controlled by central osmoreceptors situated in areas in the hypothalamic 
region that are at least partly located outside the blood-brain barrier (23). Therefore, the 
numerous angiotensin receptors present in the Organum Vasculosum of the Lamina Terminalis 
are accessible to circulating ANG II (23). Electric stimulation in the Subfornical Organ has 
been described to stimulate respiration in rats (45). These facts may explain the less well known 
respiratory effects of ANG II. Anderson found that reduction in osmolality stimulated breathing 
in dogs, and that decrease in PaCO2 was correlated to plasma renin activity and osmolality (5). 
Other animal studies corroborate involvement of ANG II in respiratory regulation as 
intravenous infusion of ANG II stimulated ventilation, and angiotensin receptor blockers 
blunted the ventilatory response to hypotension (23,46,47). ANG II also stimulates thirst and 
AVP release, and AVP in turn antagonises the ventilatory stimulation by ANG II and exerts 
some inhibitory feedback on renin release (23,48). ANG II and AVP thus integrate regulatory 
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systems of volume and osmolality, and changes in osmolality are integrated with other vital 
functions, such as breathing and vasomotor control (49). 
 Osmolality and plasma sodium in pregnancy 
Osmolality is maintained at a close range of 285-290 mOsm in the non-pregnant human, but 
in the pregnant woman osmolality is reduced by approximately 10 mOsm (11). Reduction in 
plasma osmolality is mainly a result of a decrease in plasma sodium by 3-5 mmol/L. By 12 
weeks of gestation this adaptation has stabilised, and plasma osmolality remains low until 
after delivery (11). 
Threshold for thirst and release of AVP is lowered, but release of AVP in response to 
adequate physiological stimuli correspond to the non-pregnant state. A lower osmolality is 
maintained indicating a “reset “of the osmostatic control (11). The hyponatraemia of 
pregnancy is therefore not a result of inappropriate ADH secretion as might be seen in the 
homonymous syndrome. Animal studies show that osmosensitive neurons in the 
hypothalamus, directly or indirectly, respond in similar manner to hypertonicity, ANG II, and 
relaxin (18). 
 Vasopressin in pregnancy 
Basal levels of AVP are unaltered during pregnancy, but the metabolic clearing rate of AVP 
increases from early pregnancy due to an increase in circulating AVPase produced by the 
placental trophoblasts. The level of AVPase increases fourfold reaching its maximum by term, 
and the enzyme is inactivated in the liver (50,51). Central diabetes insipidus (DI) may occur 
when AVP degradation rate exceeds rate of synthesis. Manifest DI is a rare complication to 
pregnancy, complicating 1: 30 000 pregnancies (52). DI is usually described in women with 
multiple pregnancies with higher trophoblast production of AVPase, or in women with 
impaired hepatic AVPase degradation due to preeclampsia, liver steatosis or the syndrome of 
hemolysis, elevated liver enzymes, low platelets (HELLP) (52). However, some authors have 
proposed that subclinical DI could be more common during late pregnancy than commonly 
assumed (50,53). 
DI may be treated with the synthetic AVP analogue desmopressin that only stimulates the V2 
receptors. AVPase will not inactivate desmopressin as this synthetic analogue differs from 
AVP with a modified N-terminus and an alteration to arginine in position 8 (54). Therapeutic 
indications for desmopressin are enuresis and central DI. In 10-20 times higher dosage 
desmopressin has haemostatic effects increasing plasmatic levels of factor VIII and von 
Willebrand factor as well as increasing platelet adhesiveness (55). Desmopressin is therefore 
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administered both in patients with known bleeding disorders and when platelet dysfunction is 
suspected as might occur following large obstetric bleeding. Half life of desmopressin is 6-10 
hours, by far exceeding that of AVP, hence the antidiuretic effect is long-lasting, up to 24 hours. 
A meta analysis indicated that women are more sensitive to the antidiuretic effects of 
desmopressin than men (56). These characteristics of desmopressin could have relevance when 
the drug is administered to the obstetric patient. 
 Feto-maternal electrolyte and albumin relationship 
Neonatal plasma sodium at birth varies greatly, as normal values vary between 133 and 144 
mmol/L (57). In literature fetal plasma sodium is reported equal or lower than maternal 
plasma sodium (58,59). One study found that fetal chloride was higher than maternal chloride 
at all stages of pregnancy (60). Fetal albumin is reported to be higher than maternal albumin 
at term (61-63). 
 HYPONATRAEMIA 
Plasma sodium levels vary between 136-146 mmol/L in non-pregnant subjects, but during 
pregnancy sodium decreases and normal range is 127-140 mmol/L (64). Hyponatraemia is 
usually defined as a decrease in plasma sodium level below 136 mmol/L (19), but this definition 
is obviously not applicable to pregnant women. More important than the absolute level of 
hyponatraemia is the speed with which it has developed (19). Hyponatraemia is defined as 
chronic when it has lasted longer than 48 hours, acute when it has developed within 24 hours 
(65). Plasma sodium of 128 mmol/L was the highest level of plasma sodium that caused severe 
neurological symptoms in acute hyponatraemia (66), compared to levels as low as 110 mmol/L 
not rarely seen in the almost asymptomatic patients with chronic hyponatraemia, often due to 
treatment with tiazide diuretics (65).  
Hyponatraemia causes increase in interstitial and intracellular fluid volume. Pulmonary 
oedema may develop, and cellular swelling principally causes neurological symptoms. Initial 
symptoms of cerebral oedema are irritability, headache, nausea and vomiting, and 
subsequently, convulsions and coma can occur. Severe hyponatraemic encephalopathy can 
cause respiratory arrest and death (66). 
 Female sex hormones and sensitivity to hyponatraemia 
The highest morbidity and mortality in hyponatraemic encephalopathy is seen in women of 
fertile age (24). This is believed to be caused by oestrogen that reduces the Na+-K+ ATPase 
pump activity in the brain. As a consequence sodium is hampered from leaving the brain 
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astrocytes which will impede intracellular equilibration with lower extracellular osmolality. 
This will cause cell swelling that may lead to severe neurological symptoms. Seizures, 
respiratory arrest, and brain stem herniation causing death are more frequently seen when 
women develop hyponatraemic encephalopathy (24,67). 
 Chronic hyponatraemia 
Chronic hyponatraemia is by definition hyponatraemia that has lasted longer than 48 hours 
(65). The lowering of plasma sodium may be due to excess body water, or more rarely to a 
lowering of total body sodium. In the syndrome of inappropriate ADH secretion (SIAD) 
dilutional hyponatraemia is caused by retention of water due to secretion of AVP in absence of 
physiological osmotic or non-osmotic stimulation (68). However, some authors consider only 
osmotic stimulation to be appropriate thereby creating confusion regarding the definition of 
SIAD (65). SIAD may be seen in thyroid, neurological or pulmonary diseases, and may also 
be pharmacologically induced. Chronic hyponatraemia needs to be corrected slowly, with a 
maximum rise of 24 mmol/L sodium in 48 hours, as the rise in plasma sodium should not 
exceed 0,5 mmol/L per hour. A faster correction may result in periventricular leucomalacy, a 
condition that may lead to severe neurological impairment. Aggressive correction with 
hypertonic saline is indicated only in the presence of severe neurological symptoms, which is 
rare in cases of chronic hyponatraemia. Water restriction and causal therapy are usually the 
only necessary treatments. The actual value of plasma sodium should not guide the 
intervention. 
 Acute hyponatraemia 
A lowering of plasma sodium below 136 mmol/L, or 130 mmol/L in the pregnant woman, and 
that has developed within 24 hours is considered acute (65). The speed of lowering of plasma 
sodium is more important than the actual level of plasma sodium. Ingestion or administration 
of an excess water load may cause acute hyponatraemia, and subjects with high level of AVP 
are at particularly high risk. Pain, stress, and fear are non-osmotic stimuli for AVP secretion, 
but hypovolemia and hypotension are the most potent stimuli for AVP secretion and may cause 
water retention even if osmolality is low (24). Patients are therefore particularly vulnerable in 
the perioperative setting, when a multitude of non-osmotic stimuli are present.  
Several cases of serious and even lethal hyponatraemia have been described postoperatively 
and the highest morbidity and mortality rates in hyponatraemic encephalopathy are found in 
women of fertile age (24,67). Lethal hyponatraemia has also occurred when large volumes of 
free water were ingested (69). Several healthy individuals have died from hyponatraemia 
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during endurance sports, and researches argued for decades about the pathophysiology in the 
condition known as endurance associated hyponatraemia. Individual characteristics such as 
gender or other genetic predisposing conditions and SIAD were discussed. However, a large 
prospective observational study conducted during the Boston marathon in 2002 showed that 
hyponatraemia was caused by excess water (70). Longer running time, together with very high 
or very low BMI, was also related to the development of hyponatraemia, explaining why 
female gender was previously considered a possible risk factor for hyponatraemia.  
 Hyponatraemia during labour 
The threshold for thirst and release of AVP is lowered during pregnancy, but release of AVP 
in response to adequate physiological stimuli correspond to the non-pregnant state. A lower 
osmolality is maintained indicating a “reset “of the osmostatic control (11). Retention of water 
and sodium causes dilutional hyponatraemia and is not a result of inappropriate ADH secretion 
(SIAD). Acute hyponatraemia in addition to this chronic hyponatraemia may develop during 
labour, and severe and fatal cases were described already in the 1960ies (8,9). 
In an observational study published in 1981 Tarnow-Mordi found that hyponatraemia was 
iatrogenic, mainly caused by hypotonic fluids administered intravenously (8). Hyponatraemia 
correlated to administration of OT and to epidural analgesia. For safety reasons OT was 
administered in dilute solutions, and labour epidural analgesia was at the time provided 
exclusively by local anaesthetics in concentrations of 1.25-5 mg per milliliter, which could 
cause hypotension. Intravenous cristalloids were therefore administered as preventive measure. 
The development of pump devices have permitted more concentrated solutions of OT, and with 
the addition of opioids lower concentrations of local anaesthetics are required for epidural 
analgesia.  
These changes have reduced the need for intravenous cristalloids, however, also in recent years 
several case reports of hyponatraemia during labour have been published (6,7). In most cases 
maternal or neonatal seizures have led to the diagnosis of severe hyponatraemia. Studies in 
sports medicine claiming that hydration was essential for optimal muscle performance inspired 
obstetricians to hypothesise that hydration could reduce duration of labour (71,72). However, 
a subsequent Cochrane report could not support the liberal administration of intravenous fluids 
during labour (73).  
Guidelines encouraging women to drink at least 500 milliliter per hour during labour and to 
drink to avoid thirst are still to be found on Swedish websites (74), but in a more recent 
publication the responsible midwife has reduced the advised hourly fluid intake to one small 
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glass of water (75). Diagnostic difficulties of hyponatraemia during labour are obvious, as 
initial symptoms of hyponatraemic encephalopathy are nonspecific and may easily be confused 
with symptoms of preeclampsia. 
 Health by drinking water, where is the scientific evidence? 
Researchers in sports medicine proposed for more than 30 years new principles for optimal 
muscle performance stating that loss of body weight was directly correlated to decreased 
muscular performance in endurance sports (69). The concept of “voluntary dehydration”, well 
known in the elderly, was extended also to young and fit athletes, and to prevent dehydration 
the principle of drinking so much as to avoid the sensation of thirst was advocated. These 
principles were almost universally accepted, and among the public there still is a widespread 
belief that drinking large quantities of water promotes health. In a thorough review of the 
literature Valtin could not find evidence for this assumption, nor did he find its origin (76). 
 The practice of ingesting large quantities of fluids during endurance sports has led to several 
fatalities due to hyponatraemia. A long lasting conflict raged between supporters of ingestion 
of fluids to prevent weight loss and those advocating thirst as the guide to fluid ingestion (77). 
It is now accepted that excessive fluid intake causes exercise associated hyponatraemia, 
however, hyponatraemia still occurs among athletes (78,79). A recent internet search for 
guidelines regarding fluid intake during endurance sports revealed that overdrinking was still 
advocated (80). 
Midwives often argue that labour is extremely energy consuming, and several studies have 
addressed the various nutritional policies and their effect on labour (81). One large prospective 
randomised trial showed that light meals compared to water only was neither beneficial nor 
harmful for the mother´s wellbeing or the process of labour (82). Following publication of these 
studies professionals as well as the public have questioned the “nil per mouth” policies common 
in labour wards in many parts of the world. In Sweden women have usually been allowed fluids 
and in some labour wards even solids, therefore these studies have not caused significant 
change in policies regarding food and drink during labour in Sweden. 
 
 STEWART´S PHYSICO-CHEMICAL APPROACH TO ACID–BASE 
BALANCE 
Stewart proposed in 1983 a physico-chemical approach for analysis of the correlation 
between electrolytes and acid-base balance (83). New definitions of the metabolic 
components in the acid –base analysis are cornerstones in this model. These are the strong ion 
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difference (SID), determined by the difference between the strong cations and anions, the 
non-volatile weak acid buffer (A-tot), mainly determined by the albumin concentration (84), 
and, of lesser importance, the unmeasured anions (UA) made up by sulphates, phosphates, 
and other anions that may be present in pathological conditions. SID, A-tot, and UA are the 
independent variables in Stewart´s model that determine the dependent variables pH and 
HCO3
-. Particularly the definition of HCO3
- as dependent variable challenges the 
conventional model of acid-base analysis that may even advocate infusion of HCO3
- for 
correction of metabolic acidosis. SID is usually about 40 mEq/L, and the “gap” is filled up 
with the components of the buffer base, consisting of the weak anions HCO3
- and A-tot (85). 
A decrease in SID is associated with a decrease in buffer base causing metabolic acidosis, 
and an increase in SID and buffer base will result in metabolic alkalosis. Decrease in A-tot, as 
seen in hypoalbuminaemia or haemodilution, will likewise cause metabolic alkalosis. Any 
effect on acid-base balance will be the result of changes in SID, A-tot, and if present, changes 
in UA. 
The SID in this simplified description of Stewart´s model is more correctly described as SID 
apparent (SIDa). However, as the independent variables influence each other, the more exact 
calculations require factorial correction. The SID corrected is referred to as SID effective 
(SIDe) (91). However, this distinction is not made in this thesis.  
The value and clinical relevance of Stewart´s model have been questioned, and in everyday 
practice the original formulas and calculations might have caused more confusion than 
understanding. However, nowadays APPs are available to assist clinicians, facilitating 
previously difficult calculations (86).  
Stewart´s principles have also created a general appreciation of the relationship between 
electrolytes and acid-base alterations. Metabolic acidosis caused by infusion of “normal saline” 
0,9 % was first described by Scheingraber and is now widely recognised (87). One study 
clarified the effects of acetazolamide, used for correction of the additional and primary 
metabolic alkalosis that often occurs in patients with PaCO2 retention due to chronic pulmonary 
disease (88). This study showed that acetazolamide increased plasma chloride and thereby 
reduced the metabolic alkalosis. The reduced urinary excretion of chloride and the increase in 
urinary bicarbonate caused alkalinisation of urine. This study supports Stewart´s description of 
acid-base effects of electrolytes. Gattinoni showed that electrolytes have acid base effects of 
only if plasma is equilibrated with CO2 (89). 
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 Interpretation according to Stewart of pregnancy induced changes 
The lowering of plasma sodium typical of early pregnancy will cause a decrease in SID and 
metabolic acidosis. A physiological decrease of albumin will partially compensate the acidosis, 
as albumin is a weak acid. The respiratory compensation for the resulting metabolic acidosis 
will decrease PaCO2. Thus, according to this analysis, the metabolic acidosis is primary and 
the respiratory alkalosis is compensatory. Stewarts approach has also been adopted for greater 
understanding of preeclampsia. One study performed acid-base analysis by the Stewart-Gilfix 
approach in healthy pregnant women and women with preeclampsia (90). A conventional 
analysis would not have revealed any dissimilarities as base excess was similar in both groups, 
but the difference in metabolic components became apparent when adopting the Stewart-Gilfix 
approach. The lower albumin in preeclamptic women compensated for a probable increase in 
UA, and the authors suggested that albumin levels could be a prognostic factor for the severity 
of the condition. 
 
 MYOMETRIAL CONTRACTILITY 
Coordinated and forceful myometrial contractions are necessary for labour and delivery, and 
quiescence during pregnancy until term is a prerequisite of normal pregnancy. The physiology 
of myometrial contractility is extensively studied but still not completely understood. 
Contractions are ultimately determined by influx of calcium, and several ions and different ion 
channels contribute to the complex processes, and sodium is involved in several of these 
(91,92). Animal studies have showed reduced contractility in myometrial biopsies immerged 
in fluids with low concentration of sodium (93). A slow sodium leak channel has been 
identified and is believed to reduce the membrane polarisation facilitating the action potential 
(AP) that causes contractions (94). A fast sodium channel, particular to the myometrium and 
absent in other smooth muscle cells, has been identified in rat uterus, increasing significantly 
in number towards term (95). This fast sodium channel could be involved in the propagation 
of impulses and also enhance influx of calcium. Calcium is exchanged with sodium ending 
contractions (96), and Na+-K+ pumps are also involved (91). Thus, there are several possible 
ways alterations of extracellular sodium concentrations may affect myometrial contractility. 
The role of calcium is particular to the uterus, as the influx of calcium both generates APs and 
the following contraction (96). Influx of ions is believed to reduce the membrane polarisation 
to a level when the low-voltage fast T-type calcium channel opens causing depolarisation, and 
contraction occurs mainly due to inflow of extracellular calcium through the activation of high-
voltage L-type calcium channel (96).  
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The APs may be one of two types, spike- type or plateau- type (96,97). The spike-type APs are 
shorter lasting, and therefore permit lesser influx of calcium, resulting in ragged multi-
component contractions with relatively higher frequency (97). The plateau-type APs are more 
longer lasting and therefore permit larger influx of calcium through the L-type calcium 
channels generating more forceful contractions with a smooth appearance (98). 
Recent studies have described the curves of isometric contraction by analysing the traces of 
force and its first derivate. The resulting phase portrait plots indicate that contractions following 
the spike-type APs would be less effective compared to the contractions that follow plateau-
type APs (96,99).  
Studies also have shown that strips from the same biopsy may present both spike-like and 
plateau-like APs (96), and also that only fibres, but not isolated muscle, cells can exhibit long-
lasting APs indicating the importance of cellular network (96,99). OT enhances calcium influx 
and may transform spike-type APs into plateau-type APs and increase the duration of the 
plateau, which results in more forceful contractions (100). Hyperpolarisation follows the 
plateau-type AP but is not seen after the spike-type AP, and importantly, APs are not observed 
during hyperpolarisation (98). 
Some studies have shown higher delivery rates and also increased premature deliveries in the 
days following religious fast, the so called Yom Kippur effect (26,101). There is no obvious 
explanation for this, but increased osmolality due to fasting would be a physiologic stimulation 
for AVP, therefore the impact of this hormone on myometrial contractility cannot be excluded. 
Studies have also shown that the myometrium is more sensitive to AVP than to OT (26). 
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AIMS 
 
This thesis was designed to study causes and effects of changes in plasma sodium and 
osmolality during pregnancy and labour. 
 
Study 1   
To investigate the impact of osmolality on ventilation, with the hypothesis that increased 
osmolality would decrease ventilation independently of gender, and that a decrease in 
osmolality would stimulate ventilation not only in women but also in men. 
 
Study 2 
To investigate the occurrence of hyponatraemia following labour and delivery, with the 
hypothesis that hyponatraemia may be more common in labouring women than assumed. 
 
Study 3  
To determine a possible influence of hyponatraemia on myometrial contractility, with the 
hypothesis that hyponatraemia negatively affects contractility. 
 
Study 4  
To investigate feto-maternal osmotic relationship at term with the hypothesis that, in contrast 
to literature, maternal plasma osmolality is lower than fetal levels.  
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MATERIAL AND METHODS  
 
This section includes main features of the material and methods used in the studies. Detailed 
description can be found in the separate papers. 
 
Ethical considerations 
Studies1, 2, and 4 were approved by the Regional Ethical Board at the University of Linköping, 
Sweden. Study 4 was approved by the Regional Ethical Review Board in Stockholm, Sweden. 
All patients and volunteers signed written informed consent before inclusion. 
 
Paper 1 Osmolality and breathing 
Our study participants were healthy volunteers of both sex. Ten men (mean 28 years; range 20-
40) and nine women (mean 33 years; range 22-43) were included. All women participated both 
in the follicular and luteal phase of the menstrual cycle. Each woman participated on four 
separate occasions, whereas the men participated twice. 
The subjects fasted from midnight, and had a light breakfast at home, arriving in the laboratory 
at 0800 in the morning. Following infiltration anaesthesia, a 20 G arterial line was placed in 
the radial artery and, when required, an 18 G venous line was placed. Hyperosmolality was 
induced by intravenous infusion of hypertonic saline 3%, and hypoosmolality by drinking tap 
water. Heart rate, invasive arterial blood pressure, and pulse oximetry were continuously 
measured during the whole observation period. Sensitivity to CO2 was determined by 
rebreathing tests performed before and after the fluid loading procedures. Arterial blood 
samples were collected after 30 minutes of rest (baseline), before and after the rebreathing tests, 
and every 20 minutes during the fluid loading procedures, as well as 1 hour after study 
termination. Blood gases, sodium, chloride, glucose, and haemoglobin were analysed in all 
blood samples by a point-of-care analyser. At baseline and after the fluid loading procedures 
blood samples were sent to the central laboratory for analysis of albumin, urea, and osmolality 
determined by cryoscopy. For further details see study 1. 
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Fluid loading procedures 
Water loading; the participants drank tap water 20 ml∙ (kg body wt)-1∙h-1 for 2 hours. This was 
administered as an initial volume of 400 ml of water, followed by 150-200 ml every 10 minutes 
for 2 hours, up to a total of approximately 2.5 liters. 
Hypertonic saline: Saline 3% was infused intravenously at the rate of 0.1 ml∙(kg body wt)-
1∙min-1 for 120 minutes, up to a total of approximately 1 litre.  
 
Rebreathing test 
The subjects were placed in a semirecumbent position, with the head supported by a pillow. A 
nose-clip was applied, and after breathing room air for 30 seconds through a mouthpiece with 
a heat-moisture exchanger and a capnograph, a modified Bain system without CO2 absorber 
was attached. The modified Bain system consisted of a 900 cm long, 30 mm wide tube with an 
open end (102). The internal volume of the tube was 6.4 litres, and close to the mouthpiece was 
a tube for fresh gas inflow of air with 30% O2, calculated as 75 ml (kg body wt)
-1∙ min-1. The 
rebreathing test continued for 10 minutes, when steady state was assumed to be reached. Close 
observation of the capnograph traces ensured that no breathing of CO2 free room air occurred. 
Respiratory rates, inspired fraction of O2 and end tidal (ET) CO2 were recorded. Arterial blood 
samples were collected immediately before the rebreathing test, and at steady state. ET CO2 
was correlated to PaCO2. 
 
Statistics 
Power calculation 
Drinking water 20 ml∙(kg body wt)-1∙h-1 for 2 hours can decrease plasma osmolality by 5 
mOsm/kg (43,103). Intravenous infusion of hypertonic saline 3% at the rate of 0.1 ml∙h (kg 
body wt)-1∙ min-1 for 120 minutes can be expected to increase plasma osmolality by at least 10 
mOsm/kg (43,104). Plasma osmolality is predictably altered in both cases, and the effect on 
PaCO2, if any, should be present. With 10 paired comparisons, and a 3 % coefficient of 
variation of plasma osmolality, plasma sodium, and PaCO2, 10 persons in each group would 
be sufficient to detect 5 % changes of PaCO2 with power of > 90%. 
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Analysis of results 
Variables sampled during the loading procedures were analysed using repeated measures 
ANOVA with the various subject groups as categorical predictors either using all sampling 
occasions, sampling occasions at the end of the rebreathing tests, or sampling occasions during 
the loading procedures. Decreased SID indicates metabolic acidosis according to the Stewart 
model. We therefore assessed base excess (BE), pH, and PaCO2 at the time where SID reached 
its lowest level in each individual during the fluid loading procedures, and differences from 
baseline was calculated for these variables. In order to investigate interrelationships between 
PaCO2 and SID, linear regressions were made individually for each subject. In both cases, 
ANOVA was used to assess differences from baseline with groups as categorical predictor for 
group differences. 
Reliability  
In our statistics we used the calculated values of plasma osmolality, obtained at all sample 
occasions. A Bland-Altman plot was created to compare these calculated values of plasma 
osmolality with serum osmolality determined by the method of cryoscopy, measured at 
baseline and immediately after termination of the fluid loading procedures. The Bland-Altman 
plot showed that the calculated values for plasma osmolality were consistently 12 units lower   
(4%) compared to the measured values for serum osmolality, but showed no coupling to 
osmolality levels. Changes are therefore independent of method.  
The methodological intraindividual error of the rebreathing test was calculated using the S-
method first proposed by Dahlberg (105): 
 Smethod=√ (∑di2/2n) 
where di is the difference between the i:th paired measurement and n is the number of 
differences. The methodological intra individual error of our rebreathing test was 10% for all 
groups.  
Formulas for calculation 
Plasma osmolality mOsm/kg = 2[Na] + [glucose] 
SID mmol/L= ([Na]+[K]) - [ Cl]     (85): 
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Paper 2 Hyponatraemia during labour 
Pregnant women were informed about the study during antenatal classes. All women at term 
(37 full gestational weeks) were eligible with patient refusal as the only exclusion criterion. 
308 women were included in the study. Complete data from 287 women (125 primiparas and 
162 multiparas) were included for calculation of results. 
Hyponatraemia could not be expected to develop during shorter lasting labours, and therefore 
women were recruited to permit the inclusion of at least 30 women in each of four groups 
composed according to duration of labour and obstetric outcome. In addition 30 women 
delivered by planned caesarean section were included as controls. The study continued until 
completion of all five groups. Postnatal data from infants affected by significant congenital 
malformation or disease, meconium aspiration, or sepsis were excluded from analysis. 
Oxytocin for augmentation of labour was administered in 5 % glucose at a concentration of 20 
mU/ml. Intravenous glucose could also be ordered by the obstetrician as caloric supplement. 
Ringer’s acetate was administered intravenously during epidural analgesia. Ringer’s acetate 
and ephedrine were administered intravenously for blood pressure control during caesarean 
section under regional anaesthesia. General anaesthesia was performed only in cases of 
emergency. The volume of Ringer’s acetate administered before delivery by caesarean section 
was estimated to 600 milliliter in all patients. The women were allowed to drink freely during 
labour, but no solids were permitted. 
All oral intake was registered, and combined hourly fluid consumption was calculated after 
delivery. Information regarding duration of labour, pain relief, and delivery was recorded as 
well as Apgar and any pathology in the infants´ first days of life. 
Blood samples were collected from the mothers on admission and as soon as possible following 
delivery. Clamped cord blood samples from umbilical artery and vein were collected. All blood 
samples were analysed for haemoglobin, sodium, glucose, and blood gases with a point of care 
analyser. Plasma osmolality in maternal blood samples was analysed by the method of 
cryoscopy.  
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Statistics 
Power calculation 
Patients were recruited to permit the inclusion of at least 30 women in each of four groups 
composed according to duration of labour and obstetric outcome. In addition 30 women 
delivered by planned caesarean section were included as controls. A mean decrease of the 
sodium concentration of 5 mmol/L during labour would be considered significant. The sample 
size of at least 30 women in each group was required for a 90 % power to detect a significant 
difference with a two-sided alpha error of 0.05. 
Analysis of results 
For analysis the women were reallocated to three new groups according to total fluid 
administration during labour. Women with missing data were excluded from analysis. 
Continuous variables were compared with Kruskal Wallis non-parametric test and categorical 
variables with Chi-square test if the number of subjects was appropriate, otherwise Fisher´s 
exact test was used. Univariate and multivariate logistic regression were performed to study 
the relationship between maternal hyponatraemia and parity, age, body mass index (BMI), as 
well as fluid volumes administered, epidural analgesia, and oxytocin during labour. All tests 
were two-tailed, and a p-value of < 0.05 was considered statistically significant. 
 
Paper 3 Hyponatraemia and myometrial contractility 
We obtained myometrial biopsies from 17 women (age 29-42, median 35) during planned 
caesarean section in spinal anaesthesia at term. Each biopsy was divided into 8 strips and 
mounted isometrically in a force transducer. Seven biopsies were used in the first part of the 
study. Half of the strips were immersed in the hyponatraemic study solution S containing Na 
120 mmol/L and observed for 60 minutes, followed by 60 minutes in the normonatraemic 
solution C containing Na 136 mmol/L, then again immersed in solution S for 60 minutes, and 
finally for 60 minutes in solution C. The other half of the specimens were studied in reverse 
order, being immersed for four periods of each 60 minutes in the solutions C-S-C-S. In the 
second part of the study ten biopsies were included to study the response to increasing doses 
of oxytocin in solution S and C.  
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Solutions 
Tyrode´s solution with Na 136 mmol/L used for transport and control contained (in mmol/L) 
NaCl 114, KCl 4,0. CaCl2 2,0, MgCl2 1,0, NaHCO3 21,4, NaH2PO4 1,4, Glucose 10 
Hyponatraemic study solution: Tyrode´s solution with Na 120 mmol/L contained (in mmol/L) 
NaCl 97,4, KCl 4,0. CaCl2 2,0, MgCl2 1,0, NaHCO3 21,4, NaH2PO4 1,4, Glucose 10. The 
solutions were equilibrated with a gas mixture of 95% O2 and 5% CO2.  
Phase portrait plots 
The curves of isometric force are used to create phase portrait plots by plotting the first 
derivate of the force versus isometric force (7). 
 
Statistics 
Analysis of results 
Differences in frequency, amplitude, and area under the curve (AUC) in solution S and 
solution C were analysed with Wilcoxon matched pairs test. Initial multiphasic contraction 
rates with increasing doses of oxytocin in solutions S and C were analysed with ANOVA. All 
tests were two-tailed, and a p-value ≤0. 05 was considered significant. 
 
Paper 4 Feto-maternal osmotic relationship 
We included in the study 42 healthy women with singleton pregnancy scheduled for elective 
caesarean section in spinal anaesthesia at term (38-39 weeks). However, complete data were 
obtained from only 30 women, and only the results from these women were included for 
analysis. Maternal exclusion criteria were preeclampsia, diabetes mellitus, BMI above 40 
kg/m2, renal disease, active inflammatory bowel disease, or any other condition that could infer 
with water and electrolyte balance. Only pregnancies with healthy fetuses and newborn were 
included. 
The women fasted from midnight, but were allowed clear fluids until two hours before the 
caesarean section, scheduled to be performed in the morning. Upon arrival in the operating 
theatre an intravenous cannula was placed in the antecubital vein, and blood samples were 
collected before beginning intravenous administration of acetated Ringer´s solution which 
started simultaneously with the administration of the anaesthetic (co-hydration). Spinal 
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anaesthesia was performed in the sitting position with hyperbaric bupivacaine 11-12.5 mg, 
fentanyl 12.5 µg, and morphine 0.1 mg, and the mothers were immediately placed in the supine 
position with left lateral tilt. Blood pressure was maintained with intravenous bolus doses of 
phenylephrine 25-50 µg, oxygen was delivered by nasal cannula at 2 litrer per minute. 
Monitoring included electrocardiography, non-invasive blood-pressure recorded every 2 
minutes, and pulse oximetry. Delayed cord clamping for 2 minutes was adopted as by routine 
and Apgar scores were recorded at 1, 5 and 10 minutes. 
Locations, sampling procedures, and methods for analysis 
We sampled blood from mothers immediately before caesarean section and from the umbilical 
artery and vein before cord clamping. All maternal and fetal blood samples were collected in 2 
mL syringes pre-heparinised with 30 IU of balanced heparin. Within 5 minutes the point-of 
care analyser ABL 825 Flex analysed whole blood for blood gases, plasma sodium and chloride 
with potentiometry using direct ion selective electrode (ISE). The remaining blood was 
transferred from the 2 mL syringes into two microcontainers and immediately sent to the central 
hospital laboratory for comparative analysis. The microcontainers used for analysis of 
electrolytes and albumin were pre-heparinised with 0.1 mg of lithium-heparin, the 
microcontainers used for analysis of osmolality were free of additives. The microcontainers 
were centrifuged in the central laboratory as soon as possible after arrival and the supernatant 
plasma was analysed for sodium by the method of potentiometry, also using direct ISE. Plasma 
osmolality was also immediately analysed by the method of cryoscopy. The syringes and 
microcontainers were gently rolled 10 times after filling, and a minimum of 1.2 milliliter blood 
was required for the performance of all analysis.  
Statistics 
Power analysis 
Based on the results from study 2 mean sodium difference of 2 mmol/L between mother and 
arterial cord was considered clinically significant. The sample size of 32 women and their 
newborn was required to achieve 90% power to detect a significant difference with a two 
sided alpha error of 0.05 with a SD of 2.5 mmol/L.  
Analysis of results 
Residuals of osmolality, sodium, and albumin were normally distributed. For graphic 
presentations paired differences were analysed using main effects ANOVA with method or 
patient identity as categorical predictors. Sodium was adjusted for albumin using analysis of 
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covariance (ANCOVA) and shown in the same graph. Differences between groups were also 
analysed with paired t-test and presented in tables. All tests were two-tailed, and a p-value of 
less than 0.05 was considered significant. 
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RESULTS 
All results are presented and statistically evaluated in the separate papers. This section 
features the most important results. 
Paper 1 Osmolality and breathing 
Twenty-five subjects were included in the study, but complete results were obtained only from 
the 19 who fulfilled the investigation, ten men (mean 28 years; range 20-40) and nine women 
(mean 33 years; range 22-43) .Three groups were analysed: 1) men, 2) women in the follicular 
phase of menstruation, and 3) women in the luteal phase of menstruation. There were no 
differences in BMI between men and women, but men had significantly higher systemic blood 
pressure (p=0.005). Women in the luteal phase had significantly lower PaCO2 and SID 
compared to men (p=0.002, p=0.01, respectively.) For women in follicular phase, the 
differences were not significant, (p=0.1, p=0.5, respectively). All changes were similar in men 
and women, with no difference between the follicular and the luteal phase. We therefore show 
the pooled results for all three groups in figure 1. 
For further details see study 1. 
Water loading 
The women drank on average (SD; range) 2758 (254; 2444-3160) milliliter water, the men 
drank 3170 (245; 2640-3480) milliliter water. Water loading caused reduction in plasma 
sodium, chloride, osmolality, as well as SID and BE in all individuals (Fig 1). A decrease in 
PaCO2 was observed (p=0.005, Fig 1D), and pH remained unchanged (Fig 1C).  
Salt loading 
The women received on average (SD; range) 828 (76; 733-948) milliliter saline 3%, the men 
received 951 (74; 792-1044) milliliter saline 3%. Salt loading increased plasma sodium and 
osmolality in all individuals (Fig 1). Analysis of pooled data showed absence of respiratory 
compensation (Fig 1 D). SID and BE were reduced, but arterial PaCO2 remained constant (Fig 
1D), and pH decreased (p<0.001, Fig 1C).  
Sensitivity to CO2 
We found no difference in PaCO2 increase during the rebreathing tests before or after the fluid 
loading procedures (p=0.48, Fig 1 D). 
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Figure 1. Plasma sodium, osmolality, pH, PaCO2, base excess, and strong ion difference during the observation 
time 
A) Decrease in plasma sodium at 120 minutes compared to baseline during water loading (p<0.001). Increase in 
plasma sodium at 120 minutes compared to baseline during salt loading (p<0.001). 
B) Decrease in plasma osmolality at 120 minutes compared to baseline during water loading (p<0.001). Increase 
in plasma osmolality at 120 minutes compared to baseline during salt loading (p<0.001).  
C) Lowest pH at 80 minutes compared to baseline during water loading (p=0.14). Lowest pH at 120 minutes 
compared to baseline during salt loading (p<0.001).  
D) Decrease in PaCO2 at 80 minutes compared to baseline during water loading (p=0.002). PaCO2 at 120 minutes 
compared to baseline during salt loading (p=0.65). 
E) Decrease in BE at 80 minutes compared to baseline during water loading (p<0.001). Decrease in BE at 120 
minutes compared to baseline during salt loading (p<0.001). 
F) Decrease in SID at 80 minutes compared to baseline during water loading (p<0.001). Decrease in SID at 120 
minutes compared to baseline during salt loading (p<0.001). Salt; Salt loading. Water; water loading, BE; base 
excess, SID; strong ion difference, RT; rebreathing test. Bars represent mean ± 95% confidence interval. 
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Paper 2 Hyponatraemia during labour 
We included 308 women in the study, but 21 women were later excluded as blood sample 
analyses were incomplete. Data from 287 women are included in the results (125 nulliparas 
and 162 multiparas). Baseline values regarding age, weight, plasma sodium, and plasma 
osmolality were similar in all groups. For details, see study 2. 
Sixteen women (26 %) of those who received more than 2.5 liter of fluids during labour 
developed hyponatraemia ≤130mmol/L, with a mean reduction (SD) of plasma sodium 6.7 
(2.7) mmol/L. Reduction in plasma sodium was significantly correlated to the duration of 
labour and to total fluid volume administered during labour (Fig 2), but not to hourly fluid 
intake (p=0.16). Roughly two thirds of all fluids were administered orally, the remaining third 
was administered intravenously (Figures 3 and 4). Calculated total hourly fluid volume was 
approximately 300 milliliter per hour and was similar in all women (p=0.16), with exception 
for those with shorter lasting labours. However, hourly intravenous infusion volumes were 
higher in hyponatraemic women (p<0.001). Analysis by multivariate logistic regression 
showed that maternal hyponatraemia was significantly correlated with total fluid volume 
administered during labour (p<0.001), but not with OT administration (p=0.072), or with 
epidural analgesia (p=NS). 
 
Figure 2.Plasma sodium after delivery correlated to fluids during labour. Reduction in plasma sodium was 
significantly correlated to total fluid volume (p<0.001). One woman with increased plasma sodium despite high 
fluid intake is indicated with O. Na change; maternal plasma Na change during labour. 
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Figure 3.Oral and intravenous fluids during labour in the three fluid groups (mean values used). Mean sodium 
content of intravenous fluids was 69 mmol/L. In addition to the 130 women who received oxytocin intravenously, 
93 women received Ringer’s acetate during neuraxial analgesia, and 22 women received caloric supplement as 
glucose 50 or 100 mg/ml. Sport drinks are included amongst oral fluids called “others”. Ringer: Ringer´s acetate, 
Glucose +: Glucose 50 or 100 mg/ml with Na 50 mmol/ L, Glucose-: Glucose 50 or 100 mg/ml without 
electrolytes. 
 
 
Figure 4. Fluids related to maternal hyponatraemia ≤130 mmol/L. Hourly oral fluid intake was similar in all 
women (p=0.7). Glucose was administered intravenously as energy supply to 22 women, of these 8 women 
developed hyponatraemia ≤130 mmol/L after having received a mean of 600 milliliter (range 100-1500 milliliter). 
Ringer: Ringer´s acetate, Glucose +; Glucose 50 or 100 mg/ml with Na 50 mmol/L. Glucose-; Glucose 50 or 100 
mg/ml without electrolytes. Mean values used. 
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Figure 5. Spontaneous vaginal delivery versus instrumental delivery. Na change; maternal plasma Na change 
during labour, PN; vaginal delivery, Instrumental; vaginal instrumental delivery or caesarean section with 
indication failure to progress. 
 
Maternal reduction in plasma sodium correlated with longer duration of second stage, 
instrumental delivery, and emergency caesarean for failure to progress (p< 0.001, Fig. 
5).Umbilical arterial sodium concentration showed significant correlation with postpartum 
maternal values (p < 0.001), and was higher than maternal levels, mean difference (SD) 2.8 
(2.9) mmol/L. 
 
Paper 3 Hyponatraemia and myometrial contractility 
Seventeen women age (SD) 34.9 (4.5) years participated in the study. Mean BMI was 24.4 
(5.7) kg/m2. Ten women had previously been delivered by caesarean section. For further 
details see study 3. 
First part of the study: isolated effect of hyponatraemia 
Bi-or multiphasic contractions increased from 8% to 18%, (p=0.001), and the frequency of 
contractions also increased, mean increase (SD) was 5.6 (4.2) in the hyponatraemic solution S 
(p=0.018). Amplitude decreased in three specimens, but we found no significant decrease in 
the whole group ( p=0.09). AUC increased significantly in S (p=0.018). All changes were 
reversible in solution C (Figure 6). Phase portrait plots are shown in Figure 7. 
  
  35 
 
Figure 6. Isometric contraction curves from two different biopsies. Upper panel: Area with appearance of 
multicomponent contractions indicated. Bottom trace is excluded from analysis due to technical problems. C; 
normonatraemic control solution with sodium136 mm/L, S; hyponatraemic study solution with sodium 120 
mmol/L, 1h;1 hour observation time in each solution. 
Second part of the study: combined effect of hyponatremia and oxytocin 
Initial multicomponent contraction patterns following OT increased with higher 
concentrations of OT and were more often observed in solution S. Significant difference 
between S and C after OT 0. 01 IU/ml (p = 0. 05), and after 0. 1 IU/ml (p =0. 015). 
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Figure 7. Phase portrait plots of one smooth and one biphasic contraction curve. Left panels: Monophasic, smooth 
contraction curve with its phase portrait plot. Right panels: Biphasic contraction curve with its phase portrait plot. 
 
Paper 4 Feto-maternal osmotic relationship 
Data from 30 women and their newborn were included in the study. Maternal age (SD) was 
32.4 (5.5) years, BMI was 29 (4.5) kg/m2. Caesarean section was performed at gestation 
weeks 38.8 (0.3). Infants´ weight was 3432 g (357), Apgar at 1 minute 9.3 (0.6), umbilical 
artery pH 7.3(0.1). For further details see study 4. 
Maternal osmolality was (mean; 95% confidence interval) 287.0 (285.8-288.2) mOsm/kg, 
arterial cord osmolality 289.4 (287.9-291.0) mOsm/kg, venous cord osmolality was 287.3 
(286.0-288.5) mOsm/kg. The central laboratory showed maternal sodium 137.7 (137.1-138.2) 
mmol/L, arterial cord sodium 140.2 (139.6-141.0) mmol/L, and venous cord sodium was 
138.6 (137.8-139.3) mmol/L. Maternal albumin was 34.2 (33.2-35.3) g/L, arterial cord 
albumin was 31.6 (30.6-32.7) g/L, venous cord albumin was 32.1 (30.7-33.4) g/L  
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Figure 8. Osmolality and sodium in maternal and cord blood Left panel: Osmolality. Difference between maternal 
and arterial cord, (p<0.001), difference between arterial and venous cord, (p<0.001), difference between maternal 
and venous cord (p=0.63). Right panel: Plasma sodium values from the central laboratory: Difference between 
maternal and arterial cord, (p<0.001), difference between arterial and venous cord, (p<0.001), difference between 
maternal and venous cord (p=0.021). ABL sodium is considered incorrect (see Discussion), differences are 
therefore not calculated. ABL crude; value as reported by ABL, ABL adjusted; value as reported by ABL adjusted 
for albumin. Central lab crude; value as reported by the central laboratory, Central lab adjusted; value as reported 
by the central laboratory adjusted for albumin. Correlation between albumin and sodium analysed by the central 
laboratory: p=NS. Maternal; maternal blood, A.cord; arterial cord blood, V.cord; venous cord blood. The figures 
show mean values, bars represent ± 95% confidence interval. 
We found no differences in chloride between the groups (p=NS), but chloride was 3,4 (2,9-
3,9) mmol/L higher when analysed by ABL compared to the values obtained from the central 
laboratory (p<0.001). 
 
  
Figure 9. Arterialisation of umbilical cord blood. Baseline; Chloride measured by ABL at delivery. Saturated; 
Chloride measured by ABL after arterialisation. A.cord; arterial cord blood, V.cord; venous cord blood. Bars 
represent ± 95% confidence interval 
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DISCUSSION 
Paper 1 Hyponatraemia and breathing 
Infusion of hypertonic saline 3% in healthy volunteers caused osmolality to increase and 
simultaneously hyperchloraemic metabolic acidosis developed. Drinking water caused 
osmolality to decrease, and a less pronounced metabolic acidosis when compared to salt 
loading also developed. In both instances metabolic acidosis was caused by a decrease in SID. 
All changes were similar in men and women, with no difference between the follicular and the 
luteal phase. However, no respiratory compensation was observed for the metabolic acidosis 
following infusion of saline, in contrast to respiratory compensation for the lesser metabolic 
acidosis induced by drinking water. The rebreathing tests showed that sensitivity to CO2 
remained unaltered during both fluid loading procedures, and was therefore not the cause of 
the absence of respiratory compensation during salt loading. The expected respiratory 
compensation for metabolic acidosis is usually immediate, and its magnitude can even be 
predicted. 
We interpreted this phenomenon as the human equivalent of respiratory inhibition by increased 
osmolality observed in animals (39,42). Increased osmolality suppressed thermoregulatory 
panting in animals, as hyperthermia is preferred to dehydration. Although humans have other 
means for thermoregulation, our results indicated that the inhibitory effect of increased 
osmolality on breathing is present also in humans, but without apparent physiological benefit. 
The mechanisms involved are still unclear, but may include reduction of ANG II and its 
ventilatory stimulation (23,46) together with increase in AVP that will depress ventilation (48). 
Animal studies have also indicated possible neurological pathways between the areas of 
osmosensors and the respiratory center (45). 
The respiratory stimulation of lowered osmolality was not evident, as a reduction in PaCO2 
was expected as compensation for metabolic acidosis. However, the observation period was 
short, and towards the end of the observation plasma sodium and osmolality had almost 
returned to baseline values. Longer duration of hyponatraemia, as in the pregnant woman, 
could possibly reveal an effect of lowered osmolality as described in previous studies (4,5). 
Conventionally, the metabolic acidosis in pregnant women is considered compensation for a 
primary respiratory alkalosis, in turn induced by progesterone (8), but some studies have 
interpreted reduction in SID and osmolality as the primary event, and the respiratory alkalosis 
as secondary (106,107). Our study showed that lowered plasma sodium and osmolality almost 
immediately caused respiratory alkalosis in men and non-pregnant women, and the same 
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respiratory response would be expected following pregnancy-induced hyponatraemia. The 
higher pH often seen in pregnant women compared to our study participants could also be 
caused by an additional stimulation by the complex hormonal changes in pregnancy. 
 
Paper 2 Hyponatraemia during labour 
We prospectively observed 287 women during labour and found that 26% of the women who 
received more than 2.5 liters of fluid during labour developed hyponatraemia defined as plasma 
sodium ≤130mmol/L. The mean (SD) reduction of plasma sodium of 6.3 (2.7) mmol/L in these 
16 hyponatraemic women showed that hyponatraemia had developed during labour. The 
lowest maternal sodium was 122 mmol/L, the corresponding plasma sodium of her newborn 
was 126 mmol/L, fortunately neither developed symptoms of hyponatraemia. 
With the exception of women with shorter lasting labours, all mothers included in the study 
had similar hourly fluid consumption. They drank 200 milliliter per hour, and the combined 
hourly fluid intake (drink + intravenous infusion) was approximately 300 milliliter, an 
apparently not exaggerated fluid volume. However, in longer lasting labours the cumulative 
fluid volume together with a probable increase in AVP caused significant water retention and 
a consequent reduction in plasma sodium levels. 
One study reported approximately 900 milliliter per hour as the maximum capacity of excreting 
a water load at rest in healthy women, but that this was reduced by one third in late pregnancy 
(108). 
Our results indicated that a maternal fluid overload will partly be transferred to the fetus, and 
as a consequence, the maternal urine production will be smaller than expected. Maternal fluid 
loading has also been shown to increase amniotic fluid volume, but only when hypotonic fluid 
reduced maternal osmolality (109). Hence, the capacity of excreting a water load at rest in late 
pregnancy could be reduced to a lesser extent than suggested (108). 
The women in our study received fluid volumes well below their predicted maximum capacity 
of renal excretion at rest, therefore the development of hyponatraemia would indicate increased 
AVP activity during labour. Hyponatraemia during labour caused by OT administered in 
electrolyte free solutions is well recognised. Despite this, hypotonic solutions are often used as 
a vehicle for OT, as during our study. However, our multivariate logistic regression showed 
that hyponatraemia was significantly correlated to fluid volume, but not to OT.  
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The highest morbidity and mortality rates in hyponatraemic encephalopathy are found in 
women of fertile age (66,67), considered to be caused by oestrogen induced  impairment of the 
Na+-K+ ATPase pump activity in the brain (66). Symptoms of hyponatraemia will probably 
occur first at a lower level of plasma sodium in the pregnant woman due to the physiological 
hyponatraemia of pregnancy. Also, images by computerised tomography showed reversible 
reduction in brain size during pregnancy (110). This could be a result of intracellular adaptation 
to the reduction of extracellular osmolality. 
Liberal fluid intake was probably a combined result of maternal life-style habits and favorable 
opinion regarding fluid administration amongst obstetricians and midwives. There still is a 
widespread belief in beneficial effects of abundant water intake, and two obstetric studies quite 
recent at the time of our study indicated shorter duration of labour following more abundant 
fluid administration (71,72). A subsequent Cochrane report could not support these findings 
(73), but cases of even severe hyponatraemia during labour are reported also in more recent 
years (6,111). Clearly, the potential dangers of exaggerated water intake has not spread to the 
general public. A leading midwife in Sweden, author of several books and pamphlets, after our 
study reduced her advice regarding fluid needs during labour from 500 milliliter per hour (74) 
to 100 milliliter per hour (75). However, nowhere is the risk of water intoxication explained to 
pregnant women. On the other hand, a general restriction of fluids during labour may prove 
deleterious for a dehydrated laboring woman. Fluid loss during labour may vary, and sweat, 
vomit, diuresis due to unrecognised hyperglycaemia, or a rare case of DI, as possibly occurred 
in one of our study participants, are all conditions that require fluid substitution on an individual 
basis. Drinking so much as to avoid thirst should not be advocated, and when present, the basic 
physiological signal of thirst should be satisfied. 
The communication of relevant scientific knowledge to the general public could evidently be 
improved. On the other hand, pregnant women receive much information from sources that are 
not evidence-based, and health care providers should be aware of the impact this information 
may have. A bedside registration of fluid consumption during labour would be a simple 
preventive measure against hyponatraemia. No electrolyte free solutions should be 
administered, neither for OT, nor for energy supplement. The possibility of significant 
hyponatraemia should not be forgotten during long lasting labours. 
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Paper 3 Hyponatraemia and myometrial contractility 
In study 2 we found that maternal reduction in plasma sodium correlated with longer duration 
of second stage of labour, instrumental delivery and emergency caesarean for failure to 
progress. We therefore addressed the possibility of a causal relationship in study 3. Our in vitro 
study showed that hyponatraemia caused reversible and significant increase in frequency of 
contractions without change in amplitude. We also observed significant and reversible increase 
in bi-and multiphasic contractions in the hyponatraemic solution. 
The effect of increased frequency of contractions in spontaneous labour has recently been 
addressed (112). Previously excessive uterine activity was called “hyperstimulation” as it was 
most often seen following augmentation with OT. The phenomenon has been renamed 
tachysystole, and a recent study showed that tachysystole occurred in 11% of spontaneous 
labours (112). Tachysystole was significantly associated with increased rate of caesarean 
section, non reassuring fetal heart rate, and admission to neonatal intensive care. Therefore, the 
increased frequency caused by hyponatraemia could indicate a causal relationship between 
hyponatraemia and dystocia, explaining the correlation we observed in study 2. 
Higher frequency of contractions in the hyponatraemic solution increased AUC, which would 
conventionally be interpreted as increased contractility. However, recent studies suggested 
examination of the shapes of isometric contraction curves as an alternative to AUC for 
determination of contractility. Phase portrait plots were obtained by analysing the traces of 
force and its first derivate (96,99). The resulting phase portrait plots indicated that contractions 
following bi-and multiphasic contractions curves could be less effective. We observed a 
reversible increase in bi-and multiphasic contraction curves in the hyponatraemic solution, and 
the corresponding phase portrait plots could indicate reduced contractility (Figures 6 and 7). 
The strips in hyponatraemic solution also more frequently showed initial multicomponent 
contractions when OT was added in increasing doses. In physiological conditions OT is 
secreted in a pulsative manner, and several studies have addressed the hypothesis that pulsative 
administration of OT for induction or augmentation of labour could improve the effect of 
oxytocin (113,114). A recent large randomised controlled trial showed that pulsative 
administration of OT for augmentation of labour resulted in longer lasting labours, higher 
frequency instrumental delivery, and even higher neonatal morbidity, when compared to 
continuous infusion (115). Our results offer an explanation, as the initial response to OT was 
more often multiphasic in the hyponatraemic solution, resulting in potentially ineffective 
contractions. 
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Paper 4 Feto-maternal osmotic relationship 
In study 2 we found that fetal plasma sodium was higher than the corresponding maternal 
levels. Umbilical arterial sodium was also higher than umbilical venous sodium indicating 
ongoing equilibration with maternal plasma sodium. Although fetal plasma sodium in the 
literature is reported equal or lower than maternal levels, neither reviewers nor readers 
challenged our results. Study 4 was performed to determine the feto-maternal osmotic 
relationship and also to confirm the feto-maternal sodium relationship we found in study 2. Our 
previous results were confirmed as we found that fetal plasma osmolality was higher than 
maternal osmolality due to higher fetal plasma sodium. The placenta is impermeable to 
vasopressin, and studies have indicated autonomous fetal production and regulation of 
vasopressin secretion (29,116). Autonomous fetal osmoregulation can explain the creation and 
maintenance of the feto-maternal osmotic gradient. 
Only the plasma sodium values from the central laboratory paralleled the feto-maternal osmotic 
relationship. The plasma sodium values in cord blood provided by the point of care analyser 
were erroneous due to preanalytic conditions, explained below. 
Our results in studies 1 and 4 indicated that the physiological hyponatraemia of pregnancy 
caused both a compensatory respiratory alkalosis that favours removal of fetal CO2, as well as 
an osmotic gradient that favours water transport to the fetus. This unifying explanation of 
maternal physiological adaptation and feto-maternal relationship differs from the conventional 
explanatory model that considers the respiratory alkalosis primary, and the metabolic acidosis 
compensatory (1), and does not take into account the acidifying effect of hyponatraemia. The 
application of Stewart´s principles also to analysis of physiological changes of pregnancy 
would increase understanding and acceptance when Stewart´s principles are applied to study 
pathological conditions. One recent study showed how analysis according to Stewart-Gilfix 
could offer predictive information in preeclamptic women (90). 
Our findings that maternal albumin was higher than fetal albumin is also in contradiction with 
the literature (61-63). For pharmacological feto-maternal relationships this albumin gradient is 
important, and future studies should address our findings.  
The chloride ion was for a long time considered the uninteresting counterpart of the more 
important sodium ion. However, Stewart´s physico-chemical approach to acid-base balance 
has gained acceptance, and determination of chloride is essential for calculation of SID. The 
analysis of plasma chloride, once laborious and expensive, is now easily available in everyday 
clinical practice and also provided by point of care analysers. 
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We found that plasma chloride was similar in maternal and umbilical arterial and venous blood, 
in contrast to previously reported higher fetal values (60). We measured chloride in maternal 
venous blood, whereas maternal arterial chloride would have been even higher due to the well 
known chloride shift, whereby chlorides entering the red blood cells enhance venous 
transportation of CO2 (117). Arterial plasma chloride is therefore approximately 2 mmol/L 
higher than in venous blood, and when the haematocrit is increased this difference may reach 
4 mmol/L. Our arterialised umbilical cord blood samples showed a predictable increase in 
plasma chloride of 1-5 mmol/L (Fig 9). In conclusion, despite our results indicating the 
contrary, the content of chloride in fetal blood could be higher than in maternal blood, as 
previously reported. Plasma chloride will also predictably increase in the newborn following 
the physiological rise in oxygen saturation after birth. When saline is administered to the 
newborn in need of resuscitation a resulting hyperchloraemia may contribute to metabolic 
acidosis, as often described in adults .This introduces an iatrogenic diagnostic bias particularly 
when lactate is not measured. 
 
Importance of sampling routines  
The explanation to our divergent results compared to previous studies may be found in different 
sampling techniques. 
Studies have shown improved neonatal outcome with delayed clamping of the cord (118). This 
technique has been routine in the labour ward at Kalmar County Hospital for many years and 
was adopted in study 4. Blood was sampled separately from umbilical artery and vein before 
clamping of the cord. Previous studies analysed mixed cord blood (62) which consists mainly 
of venous blood with lower plasma sodium. This could probably explain the lower fetal plasma 
sodium reported in literature. When analysis is performed on blood sampled after clamping of 
the cord, the tourniquet effect will within minutes cause a concentration of non-filterable 
constituents (119). This may explain the higher fetal albumin levels reported in previous studies 
that analysed blood sampled from the clamped cord. 
In study 4 we used heparinised syringes for sampling. The syringes were easily filled with 
maternal blood, whereas the volume of umbilical cord blood within the syringe usually was 
less than half. As a consequence, heparin diluted cord blood to a greater extent which caused 
the point of care analyser to underestimate plasma sodium in umbilical cord blood (120). This 
source of analytic error was previously described, but unfortunately we were unaware of this 
effect when we planned the study (121). However, as we also measured osmolality with the 
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independent method of cryoscopy it was evident that the point of care analyser reported 
erroneous plasma sodium values. 
All values for plasma chloride were higher when analysed with the point-of-care analyser ABL. 
A previous study reported a discrepancy between chloride values measured by the direct and 
indirect ISE, but could not explain the difference (121). Both our instruments measured 
chloride by direct ISE, and the same difference was encountered. The difference of almost 4 
mmol/L will cause an underestimation of SID potentially leading to an erroneous diagnosis of 
hyperchloraemic metabolic acidosis. This should be remembered, particularly when lactate is 
not measured. It is therefore important to recognise this discrepancy for everyday clinical 
practice and adjustments should be made according to the local platforms for analysis. 
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CONCLUSIONS 
 
Study 1   
We found that increased osmolality inhibited the expected respiratory compensation for 
metabolic acidosis in both men and women. In contrast, we observed respiratory 
compensation for the metabolic acidosis that developed during water loading. As a 
consequence, it is not evident whether this respiratory stimulation was caused by decreased 
osmolality, or by metabolic acidosis, or a combination of both. The principal effect of 
osmolality on ventilation could be that of inhibition when osmolality is increased, but this 
inhibitory effect could cease at decreased osmolality. 
 
Study 2 
We found that hyponatraemia frequently developed during prolonged labour, and that this 
was caused by ingested or intravenously administered fluids, but unrelated to oxytocin 
administration or epidural analgesia. 
 
Study 3  
Hyponatraemia caused reversible contraction pattern changes in human myometrium. 
Increased frequency and multiphasic contraction curves could indicate decreased 
contractility. 
 
Study 4   
Our results from study 2 were confirmed, as we found that fetal plasma sodium and 
osmolality were higher than maternal levels. This osmotic gradient favours water transport to 
the fetus. Therefore, maternal hyponatraemia exposes the fetus to hyponatraemia that could 
be aggravated by high fetal AVP levels during prolonged labour. We also found that maternal 
albumin was higher than fetal albumin, in contrast with previous studies. This may have 
implications for feto-maternal pharmacokinetics. 
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CLINICAL IMPLICATIONS AND FUTURE PERSPECTIVES 
The focus of this thesis was to study physiological and pathophysiological events of pregnancy 
and delivery with special emphasis on osmotic regulation.  
Lowered plasma osmolality in pregnant women has been linked to the increased ventilation 
typical of pregnancy. Our results indicated that the principal effect of osmolality on ventilation 
could be inhibitory when osmolality is increased, but this inhibitory effect could cease at 
decreased osmolality. This finding could be of some importance for treatment of patients with 
retention of CO2 due to chronic obstructive pulmonary disease. A future study could also 
address a possible interaction of hyperosmolality on the ventilatory response to hypoxia. A 
reduced response to hypoxia by hyperosmolality would be of interest in palliative medicine. 
We found that fetal osmolality was higher than maternal osmolality, due to higher fetal plasma 
sodium compared to the pregnancy induced hyponatraemia in the mother. This feto-maternal 
osmotic gradient has previously not been described. Our results indicated that the physiological 
hyponatraemia in the pregnant woman caused both a compensatory respiratory alkalosis that 
favours removal of fetal CO2, as well as an osmotic gradient that favours water transport to the 
fetus. Our unifying explanation of maternal physiological adaptation and feto-maternal 
relationship differs from the conventional explanatory model that considers the respiratory 
alkalosis primary, and the metabolic acidosis compensatory. This new approach may increase 
understanding of the complex physiology of the feto-placental unit and pathophysiology of 
pregnancy, ie preeclampsia.  
We also found that acute maternal hyponatraemia quite easily developed during labour. 
Maternal hyponatraemia could be potentially more damaging for the fetus than for the mother 
who is adapted to the chronic hyponatraemia of pregnancy. During long lasting labour fetal 
vasopressin reaches the highest levels measured in humans which could expose the fetus to the 
risk of hyponatraemic encephalopathy. In the event of fetal ischaemia the interaction with 
hyponatraemic encephalopathy could aggravate the cerebral consequences of ischaemia. 
Future studies in this area are warranted. No electrolyte free solutions should be administered 
during labour, and a bedside registration of fluid consumption would be a simple preventive 
measure against hyponatraemia. 
Our study also indicated that hyponatraemia may negatively affect myometrial contractility, 
and hyponatraemia might therefore be one of several causes of dystocia. The response to 
oxytocin might also be altered by hyponatraemia. Future studies should address these findings. 
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Pregnant women receive much information from sources that are not evidence-based, and 
health care providers should be aware of the impact this information may have. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
När en kvinna blir gravid genomgår hennes kropp stora förändringar redan innan synlig tillväxt 
av livmodern. Blodcirkulationen till alla organ ökar så väl som andningsfrekvensen. 
Illamåendet som drabbar många på morgonen är välkänd, mindre känt är dock att salthalten i 
blodet sjunker. Man har tidigare ansett att alla dessa förändringar beror på progesteron, ett 
hormon som utsöndras av äggstockarna. Vissa studier har dock sett samband mellan sjunkande 
salthalt i blodet och ökad andning. 
Sambandet mellan salthalt och andning har studerats hos djur som flåsar för att reglera 
kroppstemperaturen. Ökad salthalt i blodet uppfattas som hotande vattenbrist, och för att spara 
på vattnet slutar djur att flåsa, även om det innebär att kroppstemperaturen kan stiga.  
I studie 1 undersökte vi om salthalten i blodet påverkar andningen hos människan oberoende 
av kön. Vi studerade hur andningen ändrades när salthalten i blodet ändrades hos friska 
försökspersoner. Tio män och nio kvinnor fick vid skilda tillfällen dricka vatten så att salthalten 
i blodet sjönk, vid andra tillfällen höjdes salthalten genom att de fick saltlösning injicerat direkt 
in i blodbanan. Vid båda tillfällen blev blodet ”surare”. Vanligtvis korrigeras denna surhet 
genom att andningen ökar, och när kolsyrehalten i blodet sjunker minskar också ”surheten”. 
Hos våra försökspersoner observerade vi att andningen ökade när surheten orsakades av låg 
koncentration av salter, men när blodet blev ännu surare av saltlösningen, ökade inte 
andningen. Människan har alltså behållit kopplingen mellan salthalt i blodet och andning, och 
det verkar som att hög salthalt bromsar andningen, och att denna broms försvinner när 
salthalten i blodet sjunker. Lägre kolsyrahalt i den gravida kvinnans blod gynnar transport at 
kolsyra från fostret. 
Förutom den fysiologiska minskningen av salter i blodet hos den gravida kvinnan kan 
ytterligare minskning av salthalten (hyponatremi) uppkomma under förlossning. Det har under 
åren rapporterats flera fall av allvarliga komplikationer orsakade av hyponatremim. Vi hade 
hypotesen att lindrigare fall kunde vara vanligare än vad som tidigare har antagits. I studie 2 
observerade vi 287 kvinnor under förlossning. Det visade sig att hyponatremi var vanligt efter 
långvarig förlossning. Sexton kvinnor som under förlossning fick mer än 2.5 liter vätska 
utvecklade hyponatremi med plasmanatrium lägre än 130 mmol/L. Statistisk analys visade att 
hyponatremi var signifikant korrelerad med det totala vätskeintaget. Alla kvinnor fick liknande 
vätskevolym på cirka 3 deciliter per timme, fördelade på 2 deciliter dryck och 1 deciliter vätska 
givet som intravenös infusion. Detta förefaller inte vara överdrivet stora vätskemängder, men 
under långvarig förlossning och med en förmodad ökad unsöndring av vasopressin, ett 
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stresshormon som också minskar urinproduktionen, kunde hyponatremi utvecklas. 
Hyponatremi orsakades inte av värkstimulerande medel eller ryggbedövning. 
Vi hade också sett att hyponatremi var korrelerat till förlossning med sugklocka eller 
kejsarsnitt. I studie 3 studerade vi effekten av hyponatremi på mänsklig livmoder genom att ta 
vävnadsprover från livmodern vid planerade kejsarsnitt. Vi observerade då att hyponatremi 
orsakade att sammandragningstakten ökade och kontraktionskurvorna blev mer oregelbundna. 
Dessa förändringar försvann när salthalten återställdes, vilket skulle kunna peka på en sämre 
sammandragningsförmåga vid hyponatremi. Dessa resultat tyder på att hyponatremi kan vara 
en av flera faktorer som leder till värksvaghet. 
Vid förlossningsstudien undersökte vi salt i navelsträngsblodet direkt efter förlossning och såg 
då att barnet med få undantag hade högre salthalt i blodet än mamman. Barnets salthalt har 
tidigare angivits motsvara mammans salthalt, eller lägre. I studie 4 jämförde vi därför igen 
salthalten i navelsträngsblodet med mammans blod i samband med planerade kejsarsnitt. Vi 
kom fram till samma resultat som i studie 2, med en högre salthalt hos fostret än hos mamman. 
Högre salthalt i fostrets blod gynnar vattentransport till det ofödda barnet. Det förklarar också 
varför fostret kan drabbas av vattenförgiftning om mamman får för mycket vätska under 
förlossning. 
Sammanfattningsvis kan man konstatera att kvinnor under förlossning inte bör dricka eller ges 
stora mängder vätska intravenöst. Är hon törstig, skall hon dricka, men hon bör inte följa rådet 
att dricka så mycket att hon undviker att känna sig törstig. Saltfria lösningar bör heller inte ges 
till kvinnor under förlossning.  
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